GlassScriptPhysician profile
Della Ellis Evans
NPI 1588644744
$1,115.80
in general payments reported to CMS, 2019-2025
22 companies · $413 in 2025
The $413 reported for 2025 was more than what 78% of Geriatric Medicine (Family Medicine) providers received nationally (typical 2025 total: $119).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.54 · 2021: $26.17 · 2022: $19.03 · 2023: $281 · 2024: $334 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $180.18 | 2021-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Sumitomo Pharma America, INC. | $140.75 | 2023-2025 | Gemtesa, Myfembree |
| Lundbeck LLC | $85.01 | 2023-2025 | Rexulti |
| Pfizer INC. | $84.07 | 2024-2025 | |
| Novo Nordisk INC | $59.41 | 2019-2025 | Ozempic, Rybelsus |
| Otsuka America Pharmaceutical, INC. | $58.16 | 2024-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $54.35 | 2024-2025 | Breztri, Farxiga, Airsupra |
| Merck Sharp & Dohme LLC | $48.66 | 2023-2025 | Verquvo, Zerbaxa, Belsomra |
| Novartis Pharmaceuticals Corporation | $48.02 | 2023-2025 | |
| Exact Sciences Corporation | $45.61 | 2024-2025 | Cologuard Collection Kit |
| Amgen INC. | $41.40 | 2019-2024 | Repatha, Otezla |
| Abbvie INC. | $36.35 | 2023 | Vraylar, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.46 | 2024 | Xifaxan, Trulance |
| Axsome Therapeutics, INC. | $28.08 | 2025 | Auvelity |
| Ge Healthcare | $28.07 | 2024 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $23.85 | 2025 | Omnipod |
| Boston Scientific Corporation | $23.09 | 2025 | Watchman Flx |
| Hologic Sales and Service, LLC | $22.88 | 2023 | Aptima, Thinprep 2000 Processor |
| Viatris Specialty LLC | $20.61 | 2025 | Yupelri |
| Nestle Healthcare Nutrition INC. | $20.51 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.03 | 2022 | |
| Dexcom, INC. | $13.25 | 2023 | Dexcom G6 Transmitter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Della Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.